TCTM Enrolls Rosacea Study in 19 Weeks

Total Clinical Trial Management continues to maintain an outstanding track record of enrolling all studies early or on time as recruitment for a Phase III dermatology program completed 2 weeks ahead of schedule. Originally, the team planned to randomize 924 patients...